Search
Healthequity Inc
HQYAdd to Watchlist
103.970USD
+3.000+2.97%
Close 10-23 16:00（ET）
8.60BMarket Cap
41.63P/E TTM
Healthequity Inc (HQY) Stock Price Target & Forecast
Analyst Rating
Based on 16 analysts giving stock ratings to Healthequity Inc in the past month.
Buy
6 Strong Buy
9 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
118.845USD+29.14%
HQY Analyst Recommendation Trends
In the current month, HQY has received 9 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. HQY average Analyst price target in the last month is 118.845.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
6
6
6
6
6
6
6
6
9
10
10
9
9
9
8
8
1
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
16
16
16
16
16
16
16
16
HQY Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Microsoft Corp
MSFT
20
37
2
0
0
59
Palo Alto Networks Inc
PANW
13
30
12
1
0
56
CrowdStrike Holdings Inc
CRWD
10
30
13
1
1
55
Datadog Inc
DDOG
14
32
2
1
0
49
Zscaler Inc
ZS
13
25
11
0
0
49
ServiceNow Inc
NOW
15
29
2
2
0
48
Fortinet Inc
FTNT
3
6
30
5
1
45
Snap Inc
SNAP
1
9
31
3
0
44
Workday Inc
WDAY
8
12
21
2
0
43
MongoDB Inc
MDB
14
21
8
0
0
43
Financial Forecasting
Based on analysts' estimates, HQY EPS is projected to reach 1.152 in FY2027Q3, following reported EPS of 0.787 in FY2027Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
FY2027Q4
Forecast
0.90
1.11
1.19
1.15
1.10
Actual
0.58
0.82
0.79
--
--
Surprise
-35.24%
-26.25%
-34.00%
--
--
FAQs
What is Healthequity Inc's expected revenue for the next quarter?
Healthequity Inc's expected revenue is 347.46M.
What is Healthequity Inc's price target?
Analysts forecast that Healthequity Inc's price target is USD 118.84, with the highest forecast at USD 142.00 and the lowest forecast at USD 105.00.
How have Healthequity IncHQY's recent earnings per share performed?
The market expectation was USD 0.79, while Healthequity IncHQY's earnings per share (EPS) for the previous quarter was USD 0.82. EPS for the next quarter is expected at USD 1.15.
What is the analyst rating for Healthequity Inc?
Based on the ratings of Healthequity Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.